Response to yuce sari et al

We would like to thank Yuce Sari et al. [1] for the opportunity to further explain the reasons behind our article focusing on the importance of the ICRU Bladder Point (ICRU-BP) dose for urinary frequency and incontinence after radio(chemo)therapy and image-guided adaptive brachytherapy in locally advanced cervical cancer [2]. Our analysis was carried out within the international, prospective and multi-institutional EMBRACE I study [3], which collected information on several physician-assessed (CTCAE v.3) and patient-reported (EORTC C30 and CX24) symptoms.

Source: Radiotherapy and Oncology - February 26, 2021 Category: Radiology Authors: Sofia Spampinato, Lars U. Fokdal, Richard P ötter, Christine Haie-Meder, Jacob C. Lindegaard, Maximilian P. Schmid, Alina Sturdza, Ina M. Jürgenliemk-Schulz, Umesh Mahantshetty, Barbara Segedin, Kjersti Bruheim, Peter Hoskin, Bhavana Rai, Fleur Huang, R Tags: Letter to the Editor Source Type: research